Found: 5
Select item for more details and to access through your institution.
Evaluation of Long-Term Outcomes, Cytogenetic and Molecular Responses with Imatinib Mesylate in Early and Late Chronic-Phase Chronic Myeloid Leukemia: A Report from a Single Institute.
- Published in:
- Acta Haematologica, 2012, v. 128, n. 4, p. 223, doi. 10.1159/000339696
- By:
- Publication type:
- Article
Pretherapeutic Expression of the hOCT1 Gene Predicts a Complete Molecular Response to Imatinib Mesylate in Chronic-Phase Chronic Myeloid Leukemia.
- Published in:
- Acta Haematologica, 2012, v. 127, n. 4, p. 228, doi. 10.1159/000336610
- By:
- Publication type:
- Article
Quantification of imatinib in human serum: validation of a high-performance liquid chromatography-mass spectrometry method for therapeutic drug monitoring and pharmacokinetic assays.
- Published in:
- Drug Design, Development & Therapy, 2013, v. 7, p. 699, doi. 10.2147/DDDT.S42902
- By:
- Publication type:
- Article
Simultaneous detection of JAK2 V617F mutation and Bcr-Abl translocation in a patient with chronic myelogenous leukemia.
- Published in:
- 2008
- By:
- Publication type:
- case study
Molecular measurement of BCR-ABL transcript variations in chronic myeloid leukemia patients in cytogenetic remission.
- Published in:
- BMC Blood Disorders, 2010, v. 10, p. 7, doi. 10.1186/1471-2326-10-7
- By:
- Publication type:
- Article